3-HO-PCE
| Clinical data | |
|---|---|
| Other names | 3-HO-PCE; 3-Hydroxyeticyclidine; Hydroxyeticyclidine |
| Drug class | Dissociative; Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO |
| Molar mass | 219.328 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3-Hydroxyeticyclidine (3-HO-PCE) is a novel dissociative drug of the arylcyclohexylamine class, related to phencyclidine. It was first identified as a novel psychoactive substance in Sweden in 2017, and has subsequently been sold online as a research chemical. The toxicity and long-term safety profile of 3-HO-PCE is unknown as it has a very limited history of use.
Category:
- Drugs not assigned an ATC code